Moleculin Biotech (NASDAQ:MBRX) Rating Increased to Sell at StockNews.com
StockNews.com upgraded shares of Moleculin Biotech (NASDAQ:MBRX – Free Report) to a sell rating in a report published on Wednesday morning. Several other equities research analysts have also issued reports on the stock. HC Wainwright reissued a “buy” rating and issued a $8.00 target price on shares of Moleculin Biotech in a report on Monday. […]
StockNews.com upgraded shares of Moleculin Biotech (NASDAQ:MBRX – Free Report) to a sell rating in a report published on Wednesday morning. Several other equities research analysts have also issued reports on the stock. HC Wainwright reissued a “buy” rating and issued a $8.00 target price on shares of Moleculin Biotech in a report on Monday. […]
